Litcius/Paper detail

Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation

Francisca Pinheiro, Irantzu Pallarès, Francesca Peccati, Adrià Sánchez-Morales, Nathalia Varejão, Filipa Bezerra, David Ortega-Alarcón, Danilo González, Marcelo Osorio, Susanna Navarro, Adrián Velázquez‐Campoy, Maria Rosário Almeida, David Reverter, Félix Busquè, Ramón Alibés, Mariona Sodupe, Salvador Ventura

2022Journal of Medicinal Chemistry16 citationsDOIOpen Access PDF

Abstract

, hold the potential to become highly potent drugs to treat ATTR.

Topics & Concepts

TransthyretinTetramerChemistrySmall moleculeLigand (biochemistry)AmyloidosisRational designMolecular dynamicsComputational biologyStereochemistryBiochemistryNanotechnologyEnzymeReceptorComputational chemistryInternal medicinePathologyMedicineMaterials scienceBiologyAmyloidosis: Diagnosis, Treatment, OutcomesProtein Structure and Dynamics
Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation | Litcius